Albert Labs International (XCNQ:ABRT) Total Liabilities : C$0.51 Mil (As of Sep. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Albert Labs International Total Liabilities?

Albert Labs International's Total Liabilities for the quarter that ended in Sep. 2023 was C$0.51 Mil.

Albert Labs International's quarterly Total Liabilities declined from Mar. 2023 (C$0.53 Mil) to Jun. 2023 (C$0.50 Mil) but then increased from Jun. 2023 (C$0.50 Mil) to Sep. 2023 (C$0.51 Mil).

Albert Labs International's annual Total Liabilities increased from . 20 (C$0.00 Mil) to Dec. 2021 (C$0.86 Mil) but then declined from Dec. 2021 (C$0.86 Mil) to Dec. 2022 (C$0.53 Mil).

Albert Labs International Total Liabilities Historical Data

The historical data trend for Albert Labs International's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Albert Labs International Total Liabilities Chart

Albert Labs International Annual Data

Trend

Dec21

Dec22

Total Liabilities

0.86

0.53

Albert Labs International Quarterly Data
	Mar21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Total Liabilities	Get a 7-Day Free Trial					0.43	0.53	0.53	0.50	0.51

Albert Labs International Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Albert Labs International's Total Liabilities for the fiscal year that ended in Dec. 2022 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	0.529	+	(0	+	0
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	0.53

Total Liabilities	=	Total Assets (A: Dec. 2022 )	-	Total Equity (A: Dec. 2022 )
	=	0.164	-	-0.365
	=	0.53

Albert Labs International's Total Liabilities for the quarter that ended in Sep. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	0.498	+	(0.01	+	8.673617379884E-18
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	0.51

Total Liabilities	=	Total Assets (Q: Sep. 2023 )	-	Total Equity (Q: Sep. 2023 )
	=	0.065	-	-0.443
	=	0.51

Albert Labs International Total Liabilities Related Terms

Thank you for viewing the detailed overview of Albert Labs International's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Albert Labs International (XCNQ:ABRT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Albert Labs International Corp (XCNQ:ABRT) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

6996, Merritt Avenue, Burnaby, BC, CAN, V5J 4R6

Website

https://www.albertlabs.com

Albert Labs International Corp is a laboratory-based, clinical research and drug development enterprise addressing mental health care needs. The company is focusing on Real World Evidence (RWE) the company will initially look to commercialize its mycelium-based KRN-101 medicine and treatment with the help of clinical pathway.

Albert Labs International (XCNQ:ABRT) Headlines

No Headlines